We are live on ! Find out more
ACUR

Acura Pharmaceuticals
ACUR

Delisted

ACUR was delisted on the 22nd of February, 2017.

Back to rankings

43 hedge funds and large institutions have $23.1M invested in Acura Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 43 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

73% less call options, than puts

Call options by funds: $37K | Put options by funds: $138K

Holders
43
Holders Change
+43
Holders Change %
–
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
43
Increased
–
Reduced
–
Closed
–
Calls
$37K
Puts
$138K
Net Calls
-$101K
Net Calls Change
-$101K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
1
Essex Woodlands Management
Texas
$18.7M +$23.3M +2,058,977 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.57M +$1.88M +166,543 New
Northern Trust
3
Northern Trust
Illinois
$375K +$451K +39,933 New
Morgan Stanley
4
Morgan Stanley
New York
$270K +$325K +28,760 New
WMSA
5
Weiss Multi-Strategy Advisers
New York
$188K +$226K +20,000 New
CB
6
Commerce Bank
Missouri
$178K +$213K +18,889 New
OWD
7
Osborn Williams & Donohoe
Ohio
$148K +$178K +15,767 New
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$143K +$172K +15,216 New
CS
9
Credit Suisse
Switzerland
$117K +$140K +12,412 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$110K +$132K +11,727 New
PAM
11
Panagora Asset Management
Massachusetts
$105K +$126K +11,182 New
Mariner
12
Mariner
Kansas
$98K +$117K +10,399 New
PP
13
Paloma Partners
Connecticut
$98K +$118K +10,436 New
California Public Employees Retirement System
14
California Public Employees Retirement System
California
$86K +$104K +9,166 New
CA
15
Cortland Associates
Missouri
$83K +$99.5K +8,810 New
Barclays
16
Barclays
United Kingdom
$69K +$83.3K +7,374 New
LMF
17
LMR Master Fund
Cayman Islands
$66K +$79K +6,990 New
BFA
18
BlackRock Fund Advisors
California
$64K +$77.2K +6,829 New
Deutsche Bank
19
Deutsche Bank
Germany
$59K +$71.8K +6,355 New
HCM
20
Hodges Capital Management
Texas
$54K +$65.4K +5,790 New
Charles Schwab
21
Charles Schwab
California
$47K +$47.2K +4,180 New
Goldman Sachs
22
Goldman Sachs
New York
$44K +$53K +4,693 New
Bank of America
23
Bank of America
North Carolina
$44K +$53.1K +4,702 New
Wells Fargo
24
Wells Fargo
California
$40K +$47.5K +4,200 New
AllianceBernstein
25
AllianceBernstein
Tennessee
$35K +$41.7K +3,692 New
1
2

ACUR Hedge Fund Activity: Q2 2013 in Review

43 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Acura Pharmaceuticals (ACUR) for Q2 2013, worth a combined $23.1M.

Buyers outnumbered sellers: 43 funds opened new ACUR positions and 0 closed out — a net gain of 43 holders — while 0 added to existing stakes and 0 trimmed.

  • 43 institutional investors held Acura Pharmaceuticals (ACUR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $23.1M of Acura Pharmaceuticals stock for Q2 2013.
  • 43 funds opened new Acura Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +43 holders.

Based on aggregated 13F filings for Q2 2013.